2023

1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

   Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

2. Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy

   Molecular Cancer, Vol. 22, Núm. 1